Ontopical Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Ontopical's estimated annual revenue is currently $2M per year.(i)
  • Ontopical's estimated revenue per employee is $101,500

Employee Data

  • Ontopical has 20 Employees.(i)
  • Ontopical grew their employee count by 33% last year.

Ontopical's People

NameTitleEmail/Phone
1
Founder & Chief Product OfficerReveal Email/Phone
2
Director Sales Marketing & OperationsReveal Email/Phone
3
Director SalesReveal Email/Phone
4
Senior Frontend DeveloperReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.9M294%N/AN/A
#2
$43.4M2728%N/AN/A
#3
$14.1M9711%N/AN/A
#4
$1460M82917%$1.1BN/A
#5
$310M152720%N/AN/A
#6
$194.1M956-5%N/AN/A
#7
$223.9M1080-33%$101.6MN/A
#8
$581.3M27089%$253.1MN/A
#9
$716.2M35282%N/AN/A
#10
$801.4M394852%N/AN/A
Add Company

What Is Ontopical?

An increased focus on transparency in local and state government in recent years has created a valuable, but massive and ever-growing unstructured data set that has become impossible for any human or organization to stay on top of. Our mission is to build the world's best unbiased real-time aggregated source of local and state government information, providing real transparency and clarity on today's policies, best practices, trends and needs of local government organizations. While the competition gathers data from only limited sources and utilizes basic key-word search, ontopical continuously gathers content on a global scale and utilizes NLP topic modeling technology so that our customer can efficiently conduct days of research in seconds.

keywords:N/A

N/A

Total Funding

20

Number of Employees

$2M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ontopical News

2022-04-20 - Twitter bans ads that contradict science on climate change

... to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

2022-04-20 - Covid-19 was third leading cause of death in the United States in 2021

... to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

2022-04-06 - Can-Fite Up After Update on Topical Piclidenoson Psoriasis Treatment

By Michael Dabaie. Can-Fite BioPharma Ltd. American depositary receipts rose 5.7% to $1.29 premarket after the company said it is developing...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M205%N/A
#2
$3.5M205%N/A
#3
N/A20-17%N/A
#4
$2M20N/AN/A
#5
$2M20-5%N/A